buspirone has been researched along with Refractory Depression in 3 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Data were derived from an earlier study, designed to compare efficacy and tolerability of fixed dosage of extended-release venlafaxine, mitazapine, paroxetine, and risperidone, sodium valproate, buspirone, trazodone or thyroid hormone augmenting to paroxetine in those patients." | 2.78 | Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study. ( Cao, L; Chen, J; Fang, Y; Hong, W; Peng, D; Wu, Z; Yuan, C; Zhang, C, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Caldiroli, A | 1 |
| Capuzzi, E | 1 |
| Tagliabue, I | 1 |
| Capellazzi, M | 1 |
| Marcatili, M | 1 |
| Mucci, F | 1 |
| Colmegna, F | 1 |
| Clerici, M | 1 |
| Buoli, M | 1 |
| Dakanalis, A | 1 |
| Wu, Z | 1 |
| Chen, J | 1 |
| Yuan, C | 1 |
| Hong, W | 1 |
| Peng, D | 1 |
| Zhang, C | 1 |
| Cao, L | 1 |
| Fang, Y | 1 |
| Gaynes, BN | 1 |
| Dusetzina, SB | 1 |
| Ellis, AR | 1 |
| Hansen, RA | 1 |
| Farley, JF | 1 |
| Miller, WC | 1 |
| Stürmer, T | 1 |
1 review available for buspirone and Refractory Depression
| Article | Year |
|---|---|
Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review.
Topics: Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Second-Generation; Buspirone; Central | 2021 |
2 trials available for buspirone and Refractory Depression
| Article | Year |
|---|---|
Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Buspirone; China; Comorbidity; Cy | 2013 |
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; | 2012 |